指南-心力衰竭的最佳治疗方法-更高剂量可以更显著地减少全身炎症吗?
Alexandru Mircea Arvunescu1,2, Ruxandra Florentina Ionescu3, Silviu Ionel Dumitrescu3,4
1Department of Cardio-Thoracic Pathology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050471 Bucharest, Romania.
Journal of clinical medicine
|June 19, 2024
概括
用于治疗心力衰竭的卡维迪洛和萨库比特里尔/瓦尔萨坦,可以降低炎症标志物. 低剂量和中剂量的卡维迪洛降低了红细胞沉积率 (ESR),而高剂量的萨库比特里尔/瓦尔沙坦则降低了C反应蛋白 (CRP).
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 慢性炎症是心力衰竭病理生理学的组成部分,跨越所有喷射分数表型.
- 在心力衰竭中观察到持续的低级激活和益炎性细胞因子的合成.
- 用于慢性心力衰竭的抗重塑药物被假设具有抗炎性质.
研究的目的:
- 为了回顾评估心力衰竭患者常用的抗重塑药物的抗炎作用.
- 评估这些药物的启动或升级对关键炎症生物标志物的影响.
- 为了确定增加药物剂量是否会加剧抗炎作用.
主要方法:
- 对220名心力衰竭患者的回顾性分析.
- 评估炎症生物标志物:C反应蛋白 (CRP),红细胞沉积率 (ESR) 和纤维素原.
- 在基线和在药物开始或剂量调整后6个月后评估生物标志物水平.
主要成果:
- 卡维迪洛 (β-阻断剂) 在低剂量和中剂量下显示ESR的降低.
- 萨库比特里尔/瓦尔沙坦 (血管激素受体-尼普利辛抑制剂 - ARNI) 显示了CRP水平的降低.
- 萨库比特里尔/瓦尔沙坦的CRP降低是剂量依赖的,在高剂量时最明显.
结论:
- 低剂量和中剂量的卡维迪醇显著降低了心力衰竭患者的ESR水平.
- 中高剂量萨库比特里尔/瓦尔沙坦有效降低了CRP水平.
- 这些发现突显了特定抗重塑剂在心力衰竭管理中的抗炎潜力.
关键词:
在ACE-I中,这是一个ARB ARB.阿尔尼·阿尔尼 (Arni Arni) 是一个在CRP中使用CRP.在ESR中,ESR是最重要的.这是一个MRA MRA.这就是SGLT2i.贝塔抑制剂 贝塔抑制剂纤维素原体是一种纤维原体.心脏衰竭是因为心脏衰竭.这是一种炎症炎症炎症炎症.左心室喷射分数的部分.更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
6.6K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K